
Crohn's disease is a chronic inflammatory zzso disease that may involve any part of the gastrointestinal zzso Conventional therapy consists of zzso zzso or methotrexate, but the clinical management of Crohn's disease is significantly hampered by adverse zzso With the introduction of biological agents (such as zzso the goals of therapy have advanced, including induction of zzso with zzso healing as well as reduction in the rate of zzso surgeries and zzso Current therapy for moderate to severe Crohn's disease is based on zzso zzso which initiate treatment with zzso followed by zzso agents, and defer therapy with biological agents until patients become zzso to conventional zzso Recently, it has been shown that induction therapy with zzso and zzso in zzso Crohn's disease zzso zzso zzso is superior to current zzso zzso to induce clinical zzso The underlying molecular mechanisms responsible for these differences in clinical outcome remain to be zzso Experimental studies have demonstrated that zzso are able to induce impaired zzso of immune cells, including T cells and zzso cells, resulting in loss of tolerance and subsequent zzso Further research will have to determine whether zzso therapy zzso the mechanism of loss of tolerance in Crohn's disease, which could complicate future clinical zzso 

